Neuroprogression across the Early Course of Psychosis

Neuroprogression across the Early Course of Psychosis

ES评分 9.83333333333333

DOI 10.20900/jpbs.20200002
刊名
JPBS
年,卷(期) 2020, 5(1)
作者
作者单位

Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA 02478, USA ;
Department of Psychiatry, Harvard Medical School, Boston, MA 02215, USA ;

Abstract
Psychotic disorders are severe, debilitating, and even fatal. The development of targeted and effective interventions for psychosis depends upon on clear understanding of the timing and nature of disease progression to target processes amenable to intervention. Strong evidence suggests early and ongoing neuroprogressive changes, but timing and inflection points remain unclear and likely differ across cognitive, clinical, and brain measures. Additionally, granular evidence across modalities is particularly sparse in the “bridging years” between first episode and established illness—years that may be especially critical for improving outcomes and during which interventions may be maximally effective. Our objective is the systematic, multimodal characterization of neuroprogression through the early course of illness in a cross-diagnostic sample of patients with psychosis. We aim to (1) interrogate neurocognition, structural brain measures, and network connectivity at multiple assessments over the first eight years of illness to map neuroprogressive trajectories, and (2) examine trajectories as predictors of clinical and functional outcomes. We will recruit 192 patients with psychosis and 36 healthy controls. Assessments will occur at baseline and 8- and 16-month follow ups using clinical, cognitive, and imaging measures. We will employ an accelerated longitudinal design (ALD), which permits ascertainment of data across a longer timeframe and at more frequent intervals than would be possible in a single cohort longitudinal study. Results from this study are expected to hasten identification of actionable treatment targets that are closely associated with clinical outcomes, and identify subgroups who share common neuroprogressive trajectories toward the development of individualized treatments.
KeyWord
first episode; psychosis; imaging; cognition; longitudinal; schizophrenia
基金项目
页码 -
  • 参考文献
  • 相关文献
  • 引用本文

Kathryn E. Lewandowski*,Sylvain Bouix,Dost Ongur,Martha E. Shenton. Neuroprogression across the Early Course of Psychosis, Journal of Psychiatry and Brain Science. 2020; 5; (1). https://doi.org/10.20900/jpbs.20200002.

  • 文献评论

刘**江西中医****** 已认证✔

2026-10-27 09:54:15

这项研究的科学诉求非常有临床转化意义,跳出静态病例 - 对照比较,从动态轨迹视角寻找可干预的生物学标志物,而不是只找 “患者和正常人有什么不一样”,契合现代精神病分期干预理念。如果后续在统计层面妥善处理 ALD 的队列效应、纳入时变药物 / 复发 / DUP 协变量、采用轨迹聚类识别亚型,结果有望回答一个长期悬而未决的问题:精神病早期的神经改变,是持续进行性损伤,还是仅发病早期一过性波动?

杨**郑州大学****** 已认证✔

2026-10-23 12:43:02

本文聚焦精神病(尤其是首发精神分裂症)早期阶段的神经影像与认知纵向变化,探讨了"神经进展"这一关键科学问题——即疾病相关脑结构和功能改变是否以及如何随病程发展而演化。文章整合了多模态影像学证据与临床认知测量数据,对区分疾病进展、药物效应和正常发育混杂因素提出了严谨的方法学思考,其结论对把握早期干预的最佳时间窗、设计靶向性治疗策略具有重要指导意义。

h**湖南长沙******

2026-02-04 05:48:14

这是一篇关于精神疾病的基金报告,研究的结果有望加快确定与临床结果密切相关的可操作治疗靶点,对于开发个性化治疗方面具有一定的借鉴意义。

相关学者

相关机构